血清甲状旁腺激素水平测定在老年心力衰竭严重度评估中的应用被引量：4

Application of Serum Parathyroid Hormone Levels in Diagnosis of Elderly Heart Failure Severity

下载PDF

导出

摘要目的评价血清甲状旁腺激素水平测定在老年心力衰竭严重度评估中的的价值。方法选择76例老年心力衰竭患者,根据NYHA心功能分级,依次分为4组,分别测定患者中甲状旁腺激素水平、LVEF、NT-proBNP及6min步行距离。观察血清甲状旁腺素水平与心衰严重度的相关性。结果血清甲状旁腺激素水平在不同心功能等级中具有差异性,并随心功能级别增加而增加;血清甲状旁腺激素水平与6min步行距离及LVEF呈负相关,与NT-proBNP呈正相关。结论血清甲状旁腺激素可能作为老年心力衰竭严重程度的评估指标。 Objective To evaluate the diagnostic value of serum parathyroid hormone detection in severity assess： ment of elderly heart failure. Methods Seventy six cases of elderly patients with heart failure, according to the NYHA functional class, were divided into four groups. All patients were measured for parathyroid hormone level, LVEF, NT- proBNP and 6-minute walk distance. The relationship was observed between serum parathyroid hormone and severity of heart failure. Results The increased serum parathyroid hormone levels went in parallel with the severity of cardiac function. Serum parathyroid hormone levels were found to be negatively correlated with 6 minute walk distance and LVEF,but positively correlated with NT proBNP. Conclusion Serum parathyroid hormone may be used as the severity assessment of heart failure in elderly patients.

作者陈英刘凯符生苗黄涛

机构地区海南省人民医院检验科海南省人民医院老年病科

出处《临床输血与检验》 CAS 2014年第4期343-346,共4页 Journal of Clinical Transfusion and Laboratory Medicine

关键词心力衰竭老年血清甲状旁腺激素 Heart failure Elderly Serum parathyroid hormone

分类号 R541.6 [医药卫生—心血管疾病] R446.11 [医药卫生—诊断学]

引文网络
相关文献

参考文献10

1Schierbeck LL, Jensen TS, Bang U,et al. Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure [J]. Eur J Heart Fail, 2011,13(6):626-632.
2Gruson D, Lepoutre T, Ahn SA ,et al. Comparison be- tween intact and bioaetive parathyroid hormone assays in patients with severe heart failure [J]. Clinical Bio- chemistry, 2013, 46(4-5): 391-394.
3Weber KT, Simpson RU, Carbone LD. Vitamin D and calcium dyshomoeostasis- associated heart failure [J]. Heart, 2008, 94(5):540-541.
4Shah RV, Chen-Tournoux AA, Picard MH, et al. Galectin 3, cardiac structure and function, and long- term mortality in patients with acutely decompensated heart failure[J]. Eur J Heart Fail, 2010, 12(8):826- 832.
5Hagstrom E, Ingelsson E, Sundstrcm J,et al. Plasma parathyroid hormone and risk of congestive heart fail- ure in the community[J]. Eur J Heart Fail, 2010, 12 (11) :1186-1192.
6La'ulu SL, Roberts WL. Performance characteristics of six intact parathyroid hormone assays[J]. Am J Clin Pathol, 2010, 134(6) :930-938.
7Altay H,Zorlu Ali, Binici S,et al. Relation of Serum Parathyroid Hormone Level to Severity of Heart Fail- ure [J]. The American Journal of Cardiology, 2012, 109(2) : 252-256.
8Agapitou V, Dimopoulos S,Mpouchla A, et al . Serum intact parathyroid hormone levels independently predict exercise capacity in stable heart failure patients[J]. Int J Cardiol, 2011,146(3):462-464.
9Melamed ML, Eustace JA, Plantinga LC, et al. Third-generation parathyroid hormone assays and all- cause mortality in incident dialysis patients: the CHOICE study [J]. Nephrol Dial Transplant, 2008, 23(5) : 1650-1658.
10Loncar G, Bozic B, Dimkovic S, et al. Association ofincreased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure [J]. J Endocrinol Invest, 2011,34 (3) :78-85.